Cannabis Report
Home > Boards > US OTC > Cannabis > Terra Tech Corp. (TRTC)

HOLY CRIPES - READ THIS ALREADY AND GO

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (8) | Next 10 | Previous | Next
BidnessMan Member Profile
Member Level 
Followed By 36
Posts 4,260
Boards Moderated 0
Alias Born 04/05/16
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2018 4:32:02 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 7/11/2018 9:46:38 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/10/2018 1:23:39 PM
Cannabidiol Market Anticipates Growth as Regulatory Change Looms in U.S. NetworkNewsWire - 7/10/2018 8:45:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/6/2018 2:13:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/5/2018 1:10:54 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 7/2/2018 9:12:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2018 11:38:09 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2018 1:46:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/27/2018 2:58:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/22/2018 5:02:41 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/12/2018 5:00:12 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 6/12/2018 4:58:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2018 9:21:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/8/2018 9:22:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/6/2018 9:01:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2018 9:01:59 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/11/2018 9:01:41 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2018 4:17:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/3/2018 5:33:22 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2018 9:01:34 AM
Cannabis Industry Keeps Making Steps Forward NetworkNewsWire - 4/25/2018 8:45:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 4/24/2018 10:55:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/24/2018 9:23:46 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/19/2018 4:31:54 PM
BidnessMan Member Level  Thursday, 12/14/17 10:56:57 PM
Re: None
Post # of 263771 
HOLY CRIPES - READ THIS ALREADY AND GO TO SLEEP.

MARRY CHRISTMAS - I"M DONE WITH THE LOONY SHERIFF AND HER POSSE OF KAPOK. SEE YA"LL WHEN CALIFORNIA IS GOLDEN.

FORM 4's AND DILUTION IS BUSINESS AS USUAL. I WANT THEM TO BUILD OUT NEW JERSEY QUICKLY. I WANT THE GROW OPS FINISHED. I DON"T EXPECT TO BE A MILLIONAIRE UNTIL 2019 AND NOT A BILLIONAIRE UNTIL 2021:)

Put your TRTC stock up, Take a break and wait. The company is fine and it's a QX company not a Qb or Pink. It's a reporting company who makes every report and has been declared a Going Concern on it's last annual audit. IT IS THE ONLY US STOCK THAT IS IN THE MARIJUANA INDUSTRY THAT IS SEED TO SALE.



Here is about all the information that ones really needs ***READ IT***


Great reasons to keep TRTC in any portfolio


Terra Tech Corp.-TRTC 2018 Timeline and Holdings
**Provided by IndustryParticipant**
California

Dispensaries:

1. Reserve Santa Ana-owned-operational-
2. Blum Oakland-owned-operational
3. San Leandro-Q1 2018 Adult use launch

Cultivation:

1. Panther Humboldt-44,000 sq. ft. greenhouses-Leased-operational
2. Cultivar Salianas-244,000 sq. ft. Greenhouse-leased-operational
---------*Exact current production sq. ft. unknown)
3. Oakland-13,000 sq. ft. indoor facility- status unknown
4. Carnegie-30,000 sq. ft. warehouse property-not operational

** January 4-5th option on additional property, use unknown


Nevada

Dispensaries:

1. Las Vegas-Western-owned-operational
2. Las Vegas-Decatur-owned-operational
3. Las Vegas-West Grand-owned-operational
4. Reno-S.Virginia-owned-operational

Cultivation:

1. Two cultivation licenses-non operational
2. NuLeaf 30,000 sq. ft.-non-operational-50% ownership
3. NuLeaf 15,000 sq. ft. processing-50% ownership
---------*Status to be updated*

New Jersey

Cultivation:
340,000 sq. ft. greenhouse-operational

**Murphy Inauguration January 2018. Head of Cannabis Division assigned.

Cultivation yield estimates:
Indoor-4,000lbs+ per 12,000sq. ft. flowering canopy
Greenhouse-1 Ton per 10,000 sq. ft. flowering canopy


Recap of Sleek post - but advertising removed and spelling fixed.

So many are now saying the pattern is set for 2018 to be BOOM

And sure, patterns certainly possess predictive value but we have a lot more going on in 2018 than just the latest data point in a sequence.

The sociology-cultural climate has undergone a significant transformation in a relatively brief period of time. Just a decade ago, the dominant winning arguments against recreational legalization were concerns about adolescent usage, the gateway theory and remnants of reefer madness. Now the winning arguments are in support of ending the marijuana prohibition. In the past few years, social justice issues have moved to the forefront amid concerns about the targeting of certain minority populations, namely African Americans and Latinos, who are arrested for possession of marijuana at a much higher rate than Caucasians, even though usage rates are nearly identical. Economic arguments have also swelled in popularity with renewed focus on regulating and taxing cannabis instead of continuing to waste government funds fighting a losing war. For the first time in the history of the well-regarded Gallup poll, Republicans favoring legalization have reached a majority of 51%, an increase of 9 points in just the last year alone. In the same poll, 64% of Americans overall favored legalization.
Support for medical marijuana legalization has been polling consistently above 80% and in the latest Quinnipiac poll, an overwhelming 94% of respondents believed in the cause.

The geopolitical landscape has shifted dramatically as well, particularly in the Western Hemisphere where Mexico, Puerto Rico, Chile and Colombia have legalized medical marijuana.
Uruguay has already legalized recreational cannabis and Canada is on track to do so in the summer of 2018.

In the United States, the entire plant is now fully legal for medical purposes in 29 states, and for recreational in the District of Columbia and the following 8 states – Colorado, Washington, Oregon, California, Massachusetts, Alaska, Nevada and Maine.

Marijuana has some serious momentum in America these days.


MARIJUANA STOCKS: A CATALYST DRIVEN SECTOR

The most logical way of thinking about the cycling movement of the marijuana sector from 2014-2017 is that it is driven by catalysts.

Positive catalysts cause the eruption of manias, which can start immediately after an event or 1-2 months beforehand.
Colorado starting recreational cannabis sales in January 2014 and California/ Massachusetts/Nevada voting for recreational legalization in November 2016 are the textbook examples.

Negative catalysts end manias and start depressions, as occurred in March 2014 with the SEC halting several pot stocks, in November 2016 with Trump’s election victory increasing the likelihood of fierce prohibitionists Sessions and Christie becoming cabinet members, and in February 2017 with the Sessions/Spicer comments signaling the possibility of a federal crackdown on recreational marijuana.

Once a negative catalyst has caused a depression, the absence of any future positive catalysts ensures the depression will continue.
By the same token, positive catalysts are required to end depressions.
The last two bear markets lasted from March 2014 - February 2016 and from February 2017 - November 2017, only ending due to the 4/20/16 and 1/1/18 (CA recreational sales) catalysts, respectively.

So the idea that manias in the marijuana sector cannot last longer than 2-3 months is not supported by thoughtful analysis. With a sample size of only two manias, both ended by negative catalysts, it is more logical to conclude that negative catalysts have the power to end manias triggered by a single catalyst; otherwise, it is likely both manias would have continued for longer periods of time.

It is quite clear that the marijuana sector does not cycle randomly but due to the impact of positive catalysts, negative catalysts and longer periods with no catalysts at all.


THE CHARACTERISTICS OF CATALYSTS

Amplitude:
Positive or Negative

Duration of Effect on MJ sector:
Short: Days to Weeks
Medium: 1-2 Months
Long: 3 Months or more

Significance:
Major or Minor, rated from 1-10
Colorado in 2014 (MAJOR) -- 10
Nevada in 2016 (Minor) -- 4

Directness Quotient:
Direct Catalyst
The event itself acts as a direct catalyst, such as Colorado recreational sales on 1/1/14

Indirect Catalyst (Discussion catalyst)
Most catalysts possess more than just an event-based component.
Many times the discussion and media attention surrounding a catalytic event (can be positive or negative) and the associated emotions attached to it also acts as a catalyst itself.
The Spicer and Sessions comments initially acted as a direct catalyst, but they also led to an ongoing discussion in the media about the future possibility of a federal crackdown on marijuana.
That negative possibility caused prolonged fear, which caused a sustained sector selloff.
The lengthy period of discussion that followed the Spicer/Sessions comments and the associated investor sentiment that arose as a result are hallmarks of an indirect catalyst.
Most direct catalysts cause some type of discussion that can have a prolonged effect – it is usually just a matter of degree.
I like to think of a direct catalyst having an immediate effect and the discussion surrounding it (the indirect aspect) dictating the significance and duration of the catalyst as a whole.
The example above describes the direct and indirect nature of a negative catalyst – of course, a positive catalyst and its resultant discussion can lead to a sustained sector rally as well.


SUPER CATALYSTS
These are the biggest catalysts of all, the real game changers.
There are only two remaining:
Rescheduling of cannabis (de facto federal medical marijuana legalization)
Federal legalization of recreational cannabis



THE 2018 CATALYSTS

JANUARY 2018
California will begin sales of recreational marijuana on the first day of the new year

Amplitude:
Positive

Duration:
Long

Significance:
Major – 9

Direct Catalyst:
California is the biggest state in the union and the 6th largest economy in the world
California’s native population is 40M and annual tourists number 270M
Even just with medical sales only, they currently generate the most cannabis revenue of any state at $2 Billion
California marijuana revenue expected to grow to $5 Billion next year, taking national sales from $7B in 2017 to $10B in 2018
We’ve recently seen the Canadian pot stocks enter a mania, in part due to upcoming adult use legalization in July 2018, and California’s cannabis market is even larger

Indirect Catalyst:
Loudly signals the marijuana revolution is too strong to stop now
Huge momentum booster to kick off the new year after a dreadful 2017
Blatantly exposes the raw hypocrisy of the largest state in the union selling a federally illegal substance
The media is going to have a field day with this hypocrisy
Expect to see editorials in major newspapers around the country supporting a rescheduling of marijuana
Bigtime national media coverage on television, radio, internet, social media, blogs, forums will further the discussion and debate around rescheduling
International media coverage
Banking solutions should move to the forefront of discussion as well
Increases pressure on Congress to move cannabis to Schedule II



JANUARY/FEBRUARY 2018
Vermont legalizes recreational marijuana via legislature
Amplitude:
Positive

Duration:
Short

Significance:
Minor -- 2

Direct Catalyst:
First non-ballot recreational cannabis legalization bill gets signed into law
This bill is for non-commercial legalization, so it permits home grows and possession but not storefronts
The bill permitting commercial cultivation, production and dispensaries is likely to pass in 2nd half of the year

Indirect Catalyst:
Any historical event generates media attention and discussion
Always most difficult to be the first to do something new or different
Breaks down barriers and paves the way for other east coast states -- New Jersey, Delaware, Connecticut, Rhode Island -- to follow suit in 2018



MARCH/APRIL/MAY 2018
New Jersey legalizes recreational marijuana via legislature within first 100 days of Governor Phil Murphy’s tenure

Amplitude:
Positive

Duration:
Long

Significance:
MAJOR with a capital MJ -- 9

Direct:
Unless Delaware beats it to the punch, New Jersey would become the first state to pass commercial recreational legalization of cannabis through the legislature.
Cultivation, production and dispensary licenses are included in bill

Indirect:
Proves that Massachusetts was no fluke, now two big time northeast states are full-on legal
New Jersey would handily become the 2nd largest state by population to legalize adult use MJ
Has great potential to trigger a state legislative tsunami of recreational cannabis in 2018 as Rhode Island, Connecticut, and Delaware follow suit -- all three could legalize by year end, with Delaware being the favorite to be next
New Jersey and New York are attached at the hip and the discussion around recreational legalization in New York’s legislature will increase significantly (though I don’t expect NY to pass recreational until 2019)
The close geographic proximity to the financial epicenter of America will attract serious money interested in investing in New Jersey MJ
The population density of the NY/NJ metropolitan area is massive and citizens from surrounding states (New York, Connecticut, Pennsylvania) would make the size of the NJ cannabis market absolutely enormous – this also incentivizes those neighboring states to get their asses in gear on legislation lest they lose out on tax money to Jersey cannabis
Takes the baton from California and intensifies the drumbeat of pressure on Congress to reschedule cannabis



MAY/JUNE/JULY 2018
Epidiolex (cannabis-derived CBD) receives FDA Approval

Amplitude:
Positive

Duration:
Long

Significance:
MAJOR – 9.5

Direct:
GW Pharma’s epilepsy drug has the experimental data required to support its approval
Would become the first actual cannabis-formulated medication to receive FDA approval
Essentially 100% cannabis-derived cannabidiol (CBD), which is currently Schedule I
FDA indication for Lennox-Gastaut and Dravet Syndrome
Application submitted on 10/30/17

Indirect:
If FDA approves Epidiolex, by law the FDA/DEA will have 90 days to reschedule it.
GW Pharma is requesting Schedule IV so that is likely what will happen.
The approval and rescheduling of cannabis-derived CBD means that for the first time the federal government is admitting that CBD has medical value.
Because there are three different synthetic THC drugs that are currently FDA approved (Marinol, Syndros, Cesamet), the government has already basically admitted that THC has medical value.
Logic would follow that if CBD and THC admittedly have therapeutic value, how can the cannabis plant remain on Schedule I?
We already know that logic doesn’t motivate the FDA and DEA when it comes to the issue of rescheduling cannabis – the former is controlled by big pharma and the latter is law enforcement, two parties that stand to be hurt financially if cannabis was rescheduled.
So I don’t expect the FDA or DEA to reschedule cannabis.
However, what I do anticipate happening is that the gargantuan hypocrisy of the situation will lead to the generation of enormous media attention and public pressure to reschedule cannabis.
The public pressure will be transmitted into political pressure on Congress to reschedule cannabis as a Schedule II substance.
If Congress has not already rescheduled cannabis before Epidiolex attains FDA approval, or before Epidiolex (CBD) is rescheduled, then I anticipate that Congress will reschedule cannabis within 1-3 months of Epidiolex’s (CBD) rescheduling, most likely in the late summer or early fall.
The bottom line is the minute Epidiolex (CBD) receives FDA approval, the media attention and discussion revolving around cannabis’ imminent rescheduling will be the biggest single catalyst to hit the sector since Colorado began sales of recreational marijuana in January 2014.
So months before cannabis is actually rescheduled by Congress, the discussion around this topic will serve as an indirect catalyst to light up the MJ sector.



JULY 2018
Canada legalizes recreational marijuana and begins sales

Amplitude:
Positive

Duration:
Medium

Significance:
Major – 7

Direct:
Federal legalization of recreational cannabis in Canada is a harbinger of what’s to come for America in the next 24-36 months
Lays out a roadmap for federal legalization of medical and recreational cannabis in America
Normalizes adult use cannabis to those in government and society who still require convincing

Indirect:
If Congress has not yet rescheduled marijuana, the pressure on them to do so will continue to increase
Canada makes America’s perspective on the issue of cannabis look very antiquated
Establishes a blueprint that America can use for eventual federal legalization of recreational cannabis in 2020-2021



JULY 2018
Massachusetts begins sales of recreational marijuana

Amplitude:
Positive

Duration:
Long

Significance:
Major – 7

Direct:
The first northeast state to sell recreational marijuana in dispensaries will be a huge news story on the east coast.
Allows nearby states with legalized medical marijuana to observe firsthand that adult use cannabis sales will not destroy society via reefer madness.

Indirect:
Encourages NY, CT, RI, PA to hop on board the adult use MJ bandwagon
Until another northeast state starts selling recreational cannabis in dispensaries, Boston may become the Denver of the northeast as people from nearby states travel to purchase cannabis
Makes the tax revenue argument for adult use legalization more effective



AUGUST/SEPTEMBER/OCTOBER 2018
Congress Reschedules Cannabis as a Schedule II Drug

Amplitude:
POSITIVE

Duration:
Long

Significance:
MAJOR – 10 – This is a SUPERCATALYST

Direct:
The cumulative pressure from the biggest state in the union and the first northeast metropolis state starting sales of recreational marijuana (CA and MA, respectively), the first state in America to pass commercial recreational marijuana through the legislature (NJ) and the FDA approval of cannabis-derived CBD (Epidiolex), all occurring within the first half of 2018, ratchets up the political pressure for Congress to finally face the music and solve the hypocrisy of fraudulently maintaining cannabis as a Schedule I Drug.
The vote isn’t even close.
De facto federal legalization of medical marijuana.

Indirect:
This is the single most important event in the history of cannabis in America.
If you missed out on 2014’s Mania, you will have another chance to experience what the most extreme stage in the MJ Sector Mania Cycle feels like.
This is MANIC MANIA.
Enjoy it.

This is one of only 2 remaining SUPERCATALYSTS in the MJ sector, with the last one being federal legalization (There were three, but Colorado starting recreational sales on 1/1/14 was the first)
The number of ramifications is astounding and I can’t possibly cover them all, so I will touch on some of the most important.
Rescheduling cannabis as a Schedule II Drug will pave the way for banking to open up, as cannabis will no longer be considered federally illegal.
This is great for the industry itself, as now companies won’t have to stash hoards of cash in safes any longer.
It will also change the game in terms of access to capital.
Banks and other financial institutions will now be able to loan money to aid the growth of the industry.
Investment capital will flood the sector, as cannabis now becomes “safe” with the chance of any significant federal interference now extinguished
If there ever was a green light for an industry this is it.
Marijuana stocks will go vertical and it will feel like 2014 again.
Many will shift focus to not if, but when marijuana stocks will be allowed to uplist to Nasdaq – my guess is somewhere between June-September 2019
And now that medical marijuana is no longer federally illegal, the industry will naturally begin talking about the final SUPERCATALYST – federal legalization of recreational marijuana, the granddaddy of discussion catalysts.



NOVEMBER 2018
Michigan, Ohio and possibly Arizona on ballot for recreational marijuana

Amplitude:
Positive

Duration:
Short

Significance:
Major – 6

Direct:
Michigan and Ohio pass recreational legalization by the people
If Arizona gathers enough signatures in time, it will pass there as well

Indirect:
This would ordinarily be a pretty big deal, since the Midwest is currently a recreational cannabis desert, and in a single election, two pretty large states would put an end to that.
But everything is about timing.
And everything is relative.
After rescheduling, most catalysts will likely seem a lot less exciting than they may look on paper.
If cannabis has not been rescheduled by Congress before the elections, and Democrats win a congressional majority, then rescheduling is likely to happen quickly – so that would certainly increase the significance and strengthen the catalyst of the 2018 elections apart from MI/OH/AZ

Miscellaneous catalysts:
Delaware, Connecticut, Rhode Island and Vermont could all legalize recreational marijuana via legislature at different times throughout the year, though I expect the majority to take place in the 2nd half.
As single catalysts, none of them can compare to New Jersey, though I think Delaware is pretty significant because of the proximity to Washington DC, and Connecticut is important because it borders New York -- and if neighboring New Jersey and Connecticut pass recreational marijuana via legislature in 2018, the discussion of New York joining the gang will be pretty loud.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (8) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist